ASIA syndrome masked as recurrent angioedema: can development be predicted by genetic screening



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background: ASIA – autoimmune/inflammatory syndrome induced by adjuvants. Symptoms can be multifacial and the recurrent angioedema (AE) is one of the dominant. Genetic screening is discussed as a preemptive option. HLA type II (DRB1*0301 or in combination with HLA-B*08, DRB1*01, and DRB4), as well as the Arg620Trp polymorphism in the PTPN22 are discussed as a causative reason responsible for the development of autoimmune diseases, including ASIA syndrome [1,2].

Methods: A single center observation of 16 patients with ASIA syndrome and 10 controls. Genetic screening was performed in 14 patients from the ASIA group and 10 patients from the control group.

Results: All patients with ASIA are women, potential triggers included hyaluronic acid fillers 10/16, including in combination with breast silicone implants 1/16, follicle-stimulating hormone and human chorionic gonadotropin supplementation 1/16, arthroplasty with shoulder joint replacement 1/16, face hyaluronic acid injections 5/16 and calcium hydroxyapatite 1/16.

The sites of AE localization were face 15/16, larynx (1/16), upper (2/16) and lower extremities (1/16). There were arthralgia, myalgia, muscle weakness - 1/16, hypocomplementary urticarial vasculitis, lymphocytic colitis - 1/16, arthralgia combined with lymphadenopathy - 1/16, chronic spantaneous and solar urticaria - 1/16, fixed erythema of skin, antiphospholipid syndrome - 1/16, normocomplementemic urticarial vasculitis - 1/16, Still's disease - 1/16.

Autoimmune response was presented by autoantibodies in 10 of 16 patients. 10 patients received non-sedating antihistaminic drugs (5 in isolation, 1 with filler removal, 1 with hydroxychloroquine(HC), 3 with HC and omalizumab), 1 - tranexamic acid, 1 - danazol, 1 - HC, and 3 patients received no therapy. A combination of two genetic factors was detected in 3 patients: DRB1*0301, B1*08 (in two with Arg620Trp polymorphism). Isolated Arg620Trp polymorphism was detected in 6 patients.

Conclusion: Genetic factors were found in 9 out of 16 patients and none in control group. Further studies are needed to create reliable diagnostic and treatment algorithm.

Full Text

Restricted Access

About the authors

Darya S. Fomina

Clinical City Hospital No. 52; The First Sechenov Moscow State Medical University (Sechenov University); Astana Medical University

Email: daria_fomina@mail.ru
ORCID iD: 0000-0002-5083-6637
SPIN-code: 3023-4538
Scopus Author ID: 57201133822

Moscow Center of Allergy and Immunology, MD, Cand. Sci. (Medicine), Assistant Professor

Россия, Moscow; Moscow; Astana, Kazakhstan

Marina Lebedkina

City Clinical Hospital 52, Moscow, Russia

Author for correspondence.
Email: marina.ivanova0808@yandex.ru
ORCID iD: 0000-0002-9545-4720
SPIN-code: 1857-8154
Scopus Author ID: 57671017400

MD

Россия, 3 Pekhotnaya street, 123182 Moscow, Russia

Ekaterina A. Nikitina

Moscow City Hospital 52

Email: katrin88866@gmail.com
ORCID iD: 0000-0002-0865-8355
SPIN-code: 3507-9106
Scopus Author ID: 58527247600

MD

Россия, City Clinical Hospital 52, Moscow, Russia 3 Pekhotnaya street, 123182 Moscow, Russia

Elena V. Kovalkova

Center of Allergy and Immunology Clinical Moscow City Hospital 52

Email: ev-kovalkova@ya.ru
ORCID iD: 0000-0002-1212-3767
SPIN-code: 3078-0976
Scopus Author ID: 57219657734

MD

Россия, City Clinical Hospital 52, Moscow, Russia;

Gerelma V. Andrenova

Moscow City Hospital 52

Email: Andrenovagv@gmail.com
ORCID iD: 0000-0001-7053-3900
SPIN-code: 2891-1650
Scopus Author ID: 58131197100

MD

Россия, 3 Pekhotnaya street, 123182 Moscow, Russia;

Tatiana S. Кruglova

City Clinical Hospital 52, Moscow, Russia

Email: surckova.t@yandex.ru
ORCID iD: 0000-0002-4949-9178
SPIN-code: 2884-5000
Scopus Author ID: 57218627116

MD, Cand. Sci. (Med.)

Россия, 3 Pekhotnaya street, 123182 Moscow, Russia;

Elena N. Bobrikova

City Clinical Hospital 52, Moscow, Russia

Email: elena.bobrikova.69@mail.ru
ORCID iD: 0000-0002-6534-5902
SPIN-code: 5806-7260
Scopus Author ID: 57201135486

MD

Россия, 3 Pekhotnaya street, 123182 Moscow, Russia

Ulyana A. Markina

City Clinical Hospital 52, Moscow, Russia

Email: itcher.md@bk.ru
ORCID iD: 0000-0002-6646-4233
SPIN-code: 6424-0012
Scopus Author ID: 57827637400

MD

Россия, 3 Pekhotnaya street, 123182 Moscow, Russia

Sherzod Abdullaev

City Clinical Hospital 52, Moscow, Russia

Email: abdullaevsp@gmail.com
ORCID iD: 0000-0001-9001-1499
SPIN-code: 1727-2158
Scopus Author ID: 57207729352

PhD;

3 Pekhotnaya street, 123182 Moscow, Russia

Irina Evsegneeva

The First Sechenov Moscow State Medical University (Sechenov University), Moscow, Russia

Email: Ivevsegneeva@yandex.ru
ORCID iD: 0000-0002-6624-1363
SPIN-code: 6467-4120
Scopus Author ID: 22134195400

Dr. Sci. (Med.), Professor

Россия, 8-2 Trubetskaya str. Moscow, Russian Federation 119991

Alexander V. Karaulov

The First Sechenov Moscow State Medical University (Sechenov University)
Life Improvement by Future Technologies (LIFT) Center, Skolkovo, Russia;

Email: drkaraulov@mail.ru
ORCID iD: 0000-0002-1930-5424
SPIN-code: 4122-5565
Scopus Author ID: 58046945000

MD, Dr. Sci. (Med.), Professor, academician of the Russian Academy of Sciences

Россия, 8-2 Trubetskaya str. Moscow, Russian Federation 119991

Maryana A. Lysenko

Clinical City Hospital No. 52; The Russian National Research Medical University named after N.I. Pirogov

Email: gkb52@zdrav.mos.ru
ORCID iD: 0000-0001-6010-7975
SPIN-code: 3887-6250
Scopus Author ID: 57073213600

MD, Dr. Sci. (Medicine), Professor

Россия, 3 Pekhotnaya street, 123182 Moscow, Russia

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright © ABV-press,



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies